A biosensor device is defined by its biological, or bioinspired receptor unit with unique specificities toward corresponding analytes. These analytes are often of biological origin like DNAs of bacteria or viruses, or proteins which are generated from the immune system (antibodies, antigens) of infected or contaminated living organisms. Such analytes can also be simple molecules like glucose or pollutants when a biological receptor unit with particular specificity is available. One of many other challenges in biosensor development is the efficient signal capture of the biological recognition event (transduction). Such transducers translate the interaction of the analyte with the biological element into electrochemical, electrochemiluminescent, magnetic, gravimetric, or optical signals. In order to increase sensitivities and to lower detection limits down to even individual molecules, nanomaterials are promising candidates due to the possibility to immobilize an enhanced quantity of bioreceptor units at reduced volumes and even to act itself as transduction element. Among such nanomaterials, gold nanoparticles, semi-conductor quantum dots, polymer nanoparticles, carbon nanotubes, nanodiamonds, and graphene are intensively studied. Due to the vast evolution of this research field, this review summarizes in a non-exhaustive way the advantages of nanomaterials by focusing on nano-objects which provide further beneficial properties than “just” an enhanced surface area.

Enzymatic fuel cells use enzymes to produce energy from bioavailable substrates. However, such biofuel cells are limited by the difficult electrical wiring of enzymes to the electrode. Here we show the efficient wiring of enzymes in a conductive pure carbon nanotube matrix for the fabrication of a glucose biofuel cell (GBFC). Glucose oxidase and laccase were respectively incorporated in carbon nanotube disks by mechanical compression. The characterization of each bioelectrode shows an open circuit potential corresponding to the redox potential of the respective enzymes, and high current densities for glucose oxidation and oxygen reduction. The mediatorless GBFC delivers a high power density up to 1.3 mW cm⁻² and an open circuit voltage of 0.95 V. Moreover, the GBFC remains stable for 1 month and delivers 1 mW cm⁻² power density under physiological conditions (5×10⁻³ mol l⁻¹ glucose, pH 7). To date, these values are the best performances obtained for a GBFC.

We describe the first implanted glucose biofuel cell (GBFC) that is capable of generating sufficient power from a mammal's body fluids to act as the sole power source for electronic devices. This GBFC is based on carbon nanotube/enzyme electrodes, which utilize glucose oxidase for glucose oxidation and laccase for dioxygen reduction. The GBFC, implanted in the abdominal cavity of a rat, produces an average open-circuit voltage of 0.57 V. This implanted GBFC delivered a power output of 38.7 μW, which corresponded to a power density of 193.5 μW cm⁻² and a volumetric power of 161 μW mL⁻¹. We demonstrate that one single implanted enzymatic GBFC can power a light-emitting diode (LED), or a digital thermometer. In addition, no signs of rejection or inflammation were observed after 110 days implantation in the rat.